Vitamin D Replacement Mitigates Menopause-Associated Dyslipidaemia and Atherogenic Indices in Ovariectomized Rats; A Biochemical Study

Abstract

Background & Aim Dyslipidaemia is highly prevalent among postmenopausal women and its management represents a keystone in the prevention of the worldwide increase in cardiovascular morbidity and mortality. Therapy choices for menopause-associated dyslipidaemia are limited and a matter of debate. So, it becomes prudent to search for natural safe alternatives. Vitamin D (VD) has been acknowledged as an essential factor in cardiovascular health. Thus, we aimed to illustrate the impact of different VD status on dyslipidaemia and atherogenic indices.

Method 5 groups of rats were conducted; SHAM group fed control diet, ovariectomized rats fed control diet (OVX), ovariectomized rats fed VD-sufficient-high fat diet (HFD) (1 000 IU/ kg diet), ovariectomized rats fed VD-deficient-HFD (25 IU/ kg diet), and ovariectomized rats fed VD-replete-HFD (10 000 IU/ kg diet) for 16 weeks.

Results Dyslipidaemia with an increased atherogenic index of plasma, atherosclerosis coefficient, cardiac risk ratio, and aortic total cholesterol accumulation in addition to reduced serum 25-hydroxy-VD levels was observed in the OVX and VD-sufficient HFD versus SHAM. These findings were aggravated by VD-deficient-HFD while reversed by VD-replete-HFD. The VD-mediated abundance of aortic ATP-binding cassette transporter A1 (ABCA1) expression, reduced activity of the inflammatory Jun N-terminal kinases (JNK), and downregulation of aortic cluster of differentiation-36 (CD36) receptors expression together with increased serum total antioxidant capacity and reduced serum malondialdehyde were among the supposed mechanisms.

Conclusions Our study sheds light on alarming levels of VD deficiency among ovariectomized rats. VD repletion improved the menopause-associated dyslipidaemia and atherogenic indices through hypolipidemic, antioxidant, and anti-inflammatory effects.

Key words

Ovariectomized rats - vitamin D status - dyslipidaemia - atherogenic indices - ABCA1/JNK/CD36

• References

• 1 Gartlehner G, Patel SV, Feltner C. et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: Evidence report and systematic review for the US Preventive Services Task Force. Jama 2017; 318: 2234-2249
• 2 Tandon VR, Mahajan A, Sharma S. et al. Prevalence of cardiovascular risk factors in postmenopausal women: A rural study. J Midlife Health 2010; 1: 26-29
• 3 Jellinger PS, Handelsman Y, Rosenblit PD. et al. American Association of Clinical Endocrinologists and American College of endocrinology guidelines for Management of Dyslipidemia and Prevention of cardiovascular disease. Endocr Pract 2017; 23: 1-87
• 4 Hussain M. Intestinal lipid absorption and lipoprotein formation. Current Opinion in Lipidology 2014; 25: 200
• 5 Gao S, Liu J. Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease. Chronic Diseases and Translational Medicine 2017; 3: 89-94
• 6 Di Pietro N, Formoso G, Pandolfi A. Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. Vascular Pharmacology 2016; 84: 1-7
• 7 Choromańska B, Myśliwiec P, Choromańska K. et al. The role of CD36 receptor in the pathogenesis of atherosclerosis. Advances in clinical and experimental medicine: Official organ Wroclaw Medical University 2017; 26: 717-722
• 8 Flight MH. Protein–protein Interactions: Getting rid of JNK. Nature Reviews Drug Discovery 2008; 7: 975
• 9 Oh J, Riek AE, Zhang RM. et al. Deletion of JNK2 prevents vitamin-D-deficiency-induced hypertension and atherosclerosis in mice. The Journal of Steroid Biochemistry and Molecular Biology 2018; Mar 1 177: 179-86.
• 10 Das R, Ganapathy S, Mahabeleshwar GH. et al. Macrophage gene expression and foam cell formation are regulated by plasminogen. Circulation. 2013; 127: 1209-1218
• 11 Yin K, You Y, Swier V. et al. Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine Significance. Arteriosclerosis, thrombosis, and Vascular Biology 2015; 35: 2432-2442
• 12 Van Eck M. ATP-binding cassette transporter A1: Key player in cardiovascular and metabolic disease at local and systemic level. Curr Opin Lipidol 2014; 25: 297-303
• 13 Phan BAP, Toth PP. Dyslipidemia in women: Etiology and management. International Journal of Women's Health 2014; 6: 185
• 14 Okafor OE, Ezeanyika LUS, Nkwonta C. et al. Plasma Lipid Profiles and Atherogenic Indices of Rats Fed Raw and Processed Jack Fruit (Artocarpus heterophyllus) Seeds Diets at Different Concentrations. Cardiovascular Diseases 2015; 2: 7
• 15 Athyros VG, Tziomalos K, Doumas M et al. The effect of proprotein convertase subtilisin-kexin type 9 and its inhibition on glucose metabolism and cardiovascular risk. We should do better the second time after statins. Curr Pharm Des 2017 epub ahead of press.
• 16 Grossman DC, Curry SJ, Owens DK. et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: US Preventive Services Task Force Recommendation Statement. Jama 2017; 318: 2224-2233
• 17 Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014; 7: 69-87
• 18 Kennel KA, Drake MT, Daniel L. Hurley vitamin D deficiency in adults: When to test and how to treat. Mayo Clin Proc 2010; 85: 752-758
• 19 Ludgero-Correia A, Aguila MB, Mandarim-de-Lacerda CA. et al. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition 2012; 28: 316-323
• 20 National Research Council (NRC). Nutrient Requirements of Laboratory Animals. 1995. 4^th ed. National Academy Press; Washington, DC, USA:
• 21 Leong XF, Ng CY, Jaarin K. Animal models in cardiovascular research: Hypertension and atherosclerosis. BioMed Research International 2015
• 22 Chang E, Kim Y. Vitamin D insufficiency exacerbates adipose tissue macrophage infiltration and decreases AMPK/SIRT1 activity in obese rats. Nutrients 2017; 9: 338
• 23 Norbert WT. Clinical Guide to Laboratory Tests. Third ed Saunders W.B. Company, Philadelphia; 1995
• 24 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502
• 25 Olamoyegun MA, Oluyombo R, Asaolu SO. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Annals of African Medicine 2016; 15: 194
• 26 Tang F, Wu X, Wang T. et al. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul. Pharmacol. 2007; 46: 427-438
• 27 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
• 28 Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int 2014; 757461:
• 29 Tchkonia T, Morbeck DE, Von Zglinicki T. et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9: 667-684
• 30 Hagenau T, Vest R, Gissel TN. et al. Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: An ecologic meta-regression analysis. Osteoporos Int 2009; 20: 133-140
• 31 Le Blanc ES, Desai M, Perrin N. et al. Vitamin D levels and menopause-related symptoms. Menopause (New York, NY) 2014; 21: 1197
• 32 Drincic AT, Armas LA, Van Diest EE. et al. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity (Silver Spring) 2012; 20: 1444-1448
• 33 Schmidt N, Brandsch C, Kühne H. et al. Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice. PloS one 2012; Apr 20 7: e35316
• 34 Babaei P, Shirkouhi SG, Hosseini R. et al. Vitamin D is associated with metabotropic but not neurotrophic effects of exercise in ovariectomized rats. Diabetology & metabolic syndrome 2017; 9: 91
• 35 Rogers NH, Perfield 2nd JW, Strissel KJ. et al. Loss of ovarian function in mice results in abrogated skeletal muscle PPAR delta and FoxO1-mediated gene expression. Biochem Biophys Res Commun 2010; 392: 1-3
• 36 Abdulnour J, Doucet E, Brochu M. et al. The effect of the menopausal transition on body composition and cardiometabolic risk factors: A Montreal-Ottawa New Emerging Team group study. Menopause 2012; 19: 760-767
• 37 Nair D, Carrigan TP, Curtin RJ. et al. Association of total cholesterol/high-density lipoprotein cholesterol ratio with proximal coronary atherosclerosis detected by multislice computed tomography. Preventive Cardiology 2009; 12: 19-26
• 38 Gaziano JM, Hennekens CH, O′Donnell CJ. et al. High density lipoprotein, and risk of myocardial infarction. Circulation 1997; 96: 2520-2525
• 39 Bampi ABA, Rochitte CE, Favarato D. et al. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics 2009; 64: 675-682
• 40 Mokhtari Z, Hekmatdoost A, Nourian M. Antioxidant efficacy of vitamin D. Journal of Parathyroid Disease 2017; 5: 12
• 41 Bellanti F, Matteo M, Rollo T. et al. Sex hormones modulate circulating antioxidant enzymes: Impact of estrogen therapy. Redox Biology 2013; 1: 340-346
• 42 Oh J, Weng S, Felton SK. et al. 1, 25 (OH) 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687-698
• 43 Nishio H, Matsui K, Tsuji H. et al. Immunohistochemical study of the phosphorylated and activated form of c-Jun NH2-terminal kinase in human aorta. The Histochemical Journal 2001; 33: 167-171
• 44 Metzler B, Hu Y, Dietrich H. et al. Increased expression and activation of stress activated protein kinases/c-Jun NH(2)-terminal protein kinases in atherosclerotic lesions coincide with p53. Am J Pathol 2000; 156: 1875-1886
• 45 De Cesaris P, Starace D, Starace G. et al. Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor α leads to intercellular adhesion molecule-1 expression. Journal of Biological Chemistry 1999; 274: 28978-28982
• 46 Domazetovic V, Fontani F, Marcucci G. et al. Estrogen inhibits starvation-induced apoptosis in osteocytes by a redox-independent process involving association of JNK and glutathione S-transferase P1–1. FEBS Open Bio 2017; 7: 705-718
• 47 Ponda MP, Huang X, Odeh MA. et al. Vitamin D may not improve lipid levels: A serial clinical laboratory data study. Circulation 2012; A 126: 270-277
• 48 Vitezova A, Zillikens C, van Herpt T. et al. Vitamin D status and metabolic syndrome in the elderly: The Rotterdam Study. Eur J Endocrinol 2015; 172: 327-335
• 49 Mahmood LA, Al Saadi R, Matthews L. Vitamin D deficiency and cardio-metabolic syndrome: Is the evidence solid?. Archives of Medicine and Health Sciences 2017; 5: 229
• 50 Ponda MP, Dowd K, Finkielstein D. The short-term effects of vitamin D repletion on cholesterol: A randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2012; B 32: 2510-2515
• 51 Anastasius M, Kockx M, Jessup W. et al. Cholesterol efflux capacity: An introduction for clinicians. Am Heart J 2016; 180: 54-63
• 52 Barter PJ, Baker PW, Rye K-A. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol 2002; 13: 285-288
• 53 Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Progress in Lipid Research 2011; 50: 303-312
• 54 Vaskonen T, Mervaala E, Sumuvuori V. et al. Effects of calcium and plant sterols on serum lipids in obese Zucker rats on a low-fat diet. British Journal of Nutrition 2002; 87: 239-245
• 55 Ford ES, Ajani UA, McGuire LC. et al. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care 2005; 28: 1228-1230
• 56 Ning C, Liu L, Lv G. Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats. Lipids in Health and Disease 2015; 14: 31